Isradipine, a blood pressure medication, has been found to slow and possibly even stop the progression of the fatal Parkinson’s disease.
Professor D. James Surmeier, the lead Northwestern University team researcher, claims Isradipine rejuvenates aging dopamine cells. It is the aging dopamine cells that causes brain cells to die, which result in the symptoms of Parkinson’s disease.
The drug appears to protect dopamine neurons from death by blocking toxins. The medication can also be used to prevent Parkinson’s disease in those genetically predisposed to the disease. The disease effects more than 1 million people in the U.S. and is the second leading brain disease.